Clinical Trial Update: Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema

View source ↗

Summary

The update analyzes the availability of treatments for ACE inhibitor- and ARB-induced angioedema, summarizing current access to therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ace Inhibitor-induced Angioedema
• Angioedema
• Arb-induced Angioedema

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: ACE-I and ARB-induced Angioedema. | Status: COMPLETED